MANGALAM GLOBAL ENTERPRISE
Back to Balance Sheet
|
MANGALAM GLOBAL ENTERPRISE Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹549 Cr | ₹405 Cr | ₹422 Cr | ₹270 Cr | ₹221 Cr |
What is the latest Total Liabilities ratio of MANGALAM GLOBAL ENTERPRISE ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹549 Cr |
| Mar2024 | ₹405 Cr |
| Mar2023 | ₹422 Cr |
| Mar2022 | ₹270 Cr |
| Mar2021 | ₹221 Cr |
How is Total Liabilities of MANGALAM GLOBAL ENTERPRISE Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹549 Cr | 35.50 | |
| Mar2024 | ₹405 Cr | -4.02 | |
| Mar2023 | ₹422 Cr | 56.03 | |
| Mar2022 | ₹270 Cr | 22.36 | |
| Mar2021 | ₹221 Cr | - | |
Compare Total Liabilities of peers of MANGALAM GLOBAL ENTERPRISE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANGALAM GLOBAL ENTERPRISE | ₹410.7 Cr | 3.1% | 23.1% | -1.1% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,440.7 Cr | 1.6% | -5% | -14.6% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,760.9 Cr | 2.4% | 15.7% | -31.2% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,111.8 Cr | 2.9% | 16.4% | -6.7% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,077.6 Cr | -4.7% | 23.2% | -15.5% | Stock Analytics | |
| INDO US BIOTECH | ₹214.6 Cr | 1.2% | 7.8% | -32.4% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANGALAM GLOBAL ENTERPRISE | 3.1% |
23.1% |
-1.1% |
| SENSEX | 4.7% |
-0.1% |
3.6% |
You may also like the below Video Courses